|
Market Closed -
Nasdaq
00:00:00 04/11/2026 +03
|
5-day change | 1st Jan Change | ||
| 60.41 USD | +0.89% |
|
-1.79% | +52.70% |
| 10:05am | AtriCure, Inc., Q3 2026 Earnings Call, Nov 03, 2026 | |
| 11-04 | AtriCure Swings to Q3 Adjusted Earnings as Revenue Rises; Shares Drop After Hours | MT |
Company Valuation: AtriCure, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 3,194 | 2,064 | 1,692 | 1,490 | 1,967 | 3,073 | - | - |
| Change | - | -35.37% | -18.05% | -11.92% | 32.01% | 56.23% | - | - |
| Enterprise Value (EV) 1 | 3,210 | 2,063 | 1,623 | 1,441 | 1,873 | 2,921 | 2,846 | 2,752 |
| Change | - | -35.73% | -21.32% | -11.21% | 29.97% | 55.97% | -2.56% | -3.31% |
| P/E | 63.8x | -43.5x | -54.1x | -32.2x | -165x | 565x | 144x | 86.7x |
| PBR | 6.61x | 4.52x | 3.55x | 3.24x | 4x | 5.31x | 4.73x | 4.14x |
| PEG | - | 0x | 1.5x | -0.7x | 2.2x | -4x | 0x | 1.3x |
| Capitalization / Revenue | 11.6x | 6.25x | 4.24x | 3.2x | 3.68x | 5.07x | 4.52x | 4.02x |
| EV / Revenue | 11.7x | 6.24x | 4.06x | 3.1x | 3.5x | 4.82x | 4.19x | 3.6x |
| EV / EBITDA | -366x | -943x | 83.5x | 46.3x | 30.3x | 33.1x | 28x | 22.3x |
| EV / EBIT | -67.9x | -48.3x | -60.8x | -36x | -198x | 272x | 119x | 65.6x |
| EV / FCF | -136x | -52.9x | -216x | 1,934x | 38.8x | 55.4x | 70.1x | - |
| FCF Yield | -0.73% | -1.89% | -0.46% | 0.05% | 2.58% | 1.8% | 1.43% | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 1.09 | -1.02 | -0.66 | -0.95 | -0.24 | 0.1068 | 0.4206 | 0.6966 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 274.3 | 330.4 | 399.2 | 465.3 | 534.5 | 606.3 | 680 | 765.3 |
| EBITDA 1 | -8.776 | -2.188 | 19.45 | 31.12 | 61.77 | 88.23 | 101.6 | 123.7 |
| EBIT 1 | -47.3 | -42.67 | -26.68 | -40.01 | -9.447 | 10.75 | 23.83 | 41.98 |
| Net income 1 | 50.2 | -46.47 | -34.85 | -44.7 | -11.45 | 6.215 | 20.89 | 35.13 |
| Net Debt 1 | 16.09 | -1.265 | -68.63 | -49 | -94.05 | -151.9 | -226.6 | -320.8 |
| Reference price 2 | 69.53 | 44.38 | 35.69 | 30.56 | 39.56 | 60.41 | 60.41 | 60.41 |
| Nbr of stocks (in thousands) | 45,932 | 46,508 | 47,395 | 48,753 | 49,717 | 50,866 | - | - |
| Announcement Date | 2/15/22 A | 2/21/23 A | 2/15/24 A | 2/12/25 A | 2/17/26 A | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 565.48x | 4.82x | 33.11x | -.--% | 3.07B | |
| 36.19x | 4.26x | 16x | 2.37% | 189B | |
| 21.41x | 3.65x | 13.06x | 2.87% | 121B | |
| 26.65x | 4.77x | 16.3x | 1.17% | 118B | |
| 32.33x | 3.11x | 12.55x | 2.2% | 94.78B | |
| 18.06x | 0.21x | 13.47x | 0.7% | 64.98B | |
| 40.39x | 3.62x | 12.33x | 2.11% | 53.98B | |
| 45.22x | 11.15x | 31.32x | -.--% | 52.94B | |
| 29.79x | 7.43x | 18.98x | 1.36% | 52.3B | |
| 43.21x | 3.42x | 12.7x | 0.51% | 35.25B | |
| Average | 85.87x | 4.64x | 17.98x | 1.33% | 78.59B | |
| Weighted average by Cap. | 33.37x | 4.36x | 15.86x | 1.77% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ATRC Stock
- Valuation AtriCure, Inc.
Select your edition
All financial news and data tailored to specific country editions
